The U.S. vaccines market was valued at $16.4 billion in 2023, and is projected to reach $29.1 billion by 2033, growing at a CAGR of 5.9% from 2024 to 2033.
Report Code : A325351 | Pages : 90 | Category : Life Sciences
The North America vaccines market was valued at $18.0 billion in 2023, and is projected to reach $32.1 billion by 2033, growing at a CAGR of 5.9% from 2024 to 2033.
Report Code : A325348 | Pages : 110 | Category : Life Sciences
The global newcastle disease vaccine market was valued at $0.4 billion in 2023, and is projected to reach $0.6 billion by 2033, growing at a CAGR of 4.4% from 2024 to 2033.
Report Code : A324484 | Pages : 216 | Category : Life Sciences
